EOFLOW Co., Ltd. (KOSDAQ:294090)
South Korea · Delayed Price · Currency is KRW 1,490.00
-89.00 (-5.64%)
Mar 21, 2025, 5:10 PM KST
EOFLOW Revenue
EOFLOW had revenue of 97.91M KRW in the quarter ending March 31, 2026, a decrease of -89.90%. This brings the company's revenue in the last twelve months to 2.80B, down -44.08% year-over-year. In the year 2025, EOFLOW had annual revenue of 3.67B, down -29.99%.
Revenue (ttm)
2.80B
Revenue Growth
-44.08%
P/S Ratio
18.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
51.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.67B | -1.57B | -29.99% |
| Dec 31, 2024 | 5.24B | -1.35B | -20.45% |
| Dec 31, 2023 | 6.59B | -118.66M | -1.77% |
| Dec 31, 2022 | 6.71B | 6.01B | 867.57% |
| Dec 31, 2021 | 693.27M | 671.61M | 3,101.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 718.78B |
| Value Added Technology | 430.30B |
| CLASSYS | 346.88B |
| Vieworks | 243.11B |
| T&L Co., Ltd. | 157.91B |
| BioNote | 122.44B |
| Dongbang Medical | 117.37B |
| Shinhung | 104.15B |
EOFLOW News
- 20 days ago - EOFLOW Quarterly report: Q1 2026 - Filings
- 2 months ago - EOFLOW Annual report: Q4 2025 - Filings
- 2 months ago - EOFLOW Quarterly report: Q4 2025 - Filings
- 7 months ago - EOFLOW Quarterly report: Q3 2025 - Filings
- 10 months ago - EOFLOW Quarterly report: Q2 2025 - Filings